Global Contrast-Enhanced Mammography Market Growth 2026-2032
The global Contrast-Enhanced Mammography market size is predicted to grow from US$ 295 million in 2025 to US$ 451 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.
Contrast-Enhanced Mammography (CEM) is a breast imaging technique that builds on standard digital mammography by administering intravenous iodinated contrast and acquiring dual-energy images (low- and high-energy) to reconstruct enhancement/“iodine-only” images. It provides both anatomic detail (similar to conventional mammography) and functional information related to vascularity and permeability, making contrast uptake more conspicuous in many cancers. CEM is particularly relevant for dense breasts, problem-solving in equivocal cases, scenarios where breast MRI is contraindicated or less accessible, and selected pathways such as preoperative evaluation and treatment follow-up. Its clinical and operational value depends on standardized contrast administration and timing, a robust dual-energy imaging chain, and workflow-integrated reading and reporting—so performance gains translate into reproducible, scalable practice. In 2025, global Contrast-Enhanced Mammography production reached approximately 1506 unit and price is about 200 K USD/Unit.The average gross profit margin of this product is 50%.
Sustained demand for earlier detection and higher-throughput breast imaging is pushing radiology departments to adopt solutions that improve sensitivity without disrupting established mammography infrastructure. CEM supports “bringing enhancement capability onto the mammography platform,” leveraging familiar equipment ecosystems and scalable protocols. For providers, CEM can serve as a complementary—or in selected indications, alternative—pathway to breast MRI, helping shorten diagnostic timelines, improve access, and align enhancement imaging with existing mammography workflows, QC frameworks, and staffing models. CEM combines contrast administration, radiation-based imaging, and workflow governance, meaning implementation barriers extend beyond hardware to patient screening (e.g., contrast reactions and renal considerations), timing control, emergency readiness, and cross-team coordination. Clinically, positioning CEM alongside MRI, ultrasound, and tomosynthesis requires clear boundaries and standardized interpretation training to avoid excessive false positives or unnecessary follow-ups. Without strong evidence loops and disciplined QC, hospitals may face uncertainty in defining CEM’s role and sustaining consistent utilization. Demand is shifting from single-test accuracy to pathway-level efficiency—linking CEM with tomosynthesis, targeted ultrasound, biopsy workflows, and preoperative decision-making to enable faster, more streamlined “test-to-decision” cycles. In practice, CEM is often expected to deliver the greatest incremental value in dense breasts, lesion stratification, and MRI-limited populations, with gradual expansion into higher-frequency follow-up and recurrence surveillance scenarios. Meanwhile, radiology leaders increasingly prioritize structured reporting, AI assistance, and cross-site consistency to operationalize quality at scale. The upstream value chain is anchored by “contrast agent & injection systems + dual-energy mammography platform + software/QA components.” Iodinated contrast media and injectors/consumables define administration stability and safety boundaries; dual-energy detectors, x-ray tubes, generators, and compression mechanics drive image consistency and reproducibility; and reconstruction/post-processing software (low-energy images, iodine/enhancement images, artifact suppression, dose management) determines readability and workflow efficiency. Competitive differentiation concentrates on balancing low dose with high contrast, user-friendly reconstruction and reading software, integration with RIS/PACS and structured reporting, and lifecycle QA and service delivery capabilities.
LP Information, Inc. (LPI) ' newest research report, the “Contrast-Enhanced Mammography Industry Forecast” looks at past sales and reviews total world Contrast-Enhanced Mammography sales in 2025, providing a comprehensive analysis by region and market sector of projected Contrast-Enhanced Mammography sales for 2026 through 2032. With Contrast-Enhanced Mammography sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contrast-Enhanced Mammography industry.
This Insight Report provides a comprehensive analysis of the global Contrast-Enhanced Mammography landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contrast-Enhanced Mammography portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contrast-Enhanced Mammography market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contrast-Enhanced Mammography and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contrast-Enhanced Mammography.
This report presents a comprehensive overview, market shares, and growth opportunities of Contrast-Enhanced Mammography market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Contrast-Enhanced Mammography market?
What factors are driving Contrast-Enhanced Mammography market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contrast-Enhanced Mammography market opportunities vary by end market size?
How does Contrast-Enhanced Mammography break out by Type, by Application?
Contrast-Enhanced Mammography (CEM) is a breast imaging technique that builds on standard digital mammography by administering intravenous iodinated contrast and acquiring dual-energy images (low- and high-energy) to reconstruct enhancement/“iodine-only” images. It provides both anatomic detail (similar to conventional mammography) and functional information related to vascularity and permeability, making contrast uptake more conspicuous in many cancers. CEM is particularly relevant for dense breasts, problem-solving in equivocal cases, scenarios where breast MRI is contraindicated or less accessible, and selected pathways such as preoperative evaluation and treatment follow-up. Its clinical and operational value depends on standardized contrast administration and timing, a robust dual-energy imaging chain, and workflow-integrated reading and reporting—so performance gains translate into reproducible, scalable practice. In 2025, global Contrast-Enhanced Mammography production reached approximately 1506 unit and price is about 200 K USD/Unit.The average gross profit margin of this product is 50%.
Sustained demand for earlier detection and higher-throughput breast imaging is pushing radiology departments to adopt solutions that improve sensitivity without disrupting established mammography infrastructure. CEM supports “bringing enhancement capability onto the mammography platform,” leveraging familiar equipment ecosystems and scalable protocols. For providers, CEM can serve as a complementary—or in selected indications, alternative—pathway to breast MRI, helping shorten diagnostic timelines, improve access, and align enhancement imaging with existing mammography workflows, QC frameworks, and staffing models. CEM combines contrast administration, radiation-based imaging, and workflow governance, meaning implementation barriers extend beyond hardware to patient screening (e.g., contrast reactions and renal considerations), timing control, emergency readiness, and cross-team coordination. Clinically, positioning CEM alongside MRI, ultrasound, and tomosynthesis requires clear boundaries and standardized interpretation training to avoid excessive false positives or unnecessary follow-ups. Without strong evidence loops and disciplined QC, hospitals may face uncertainty in defining CEM’s role and sustaining consistent utilization. Demand is shifting from single-test accuracy to pathway-level efficiency—linking CEM with tomosynthesis, targeted ultrasound, biopsy workflows, and preoperative decision-making to enable faster, more streamlined “test-to-decision” cycles. In practice, CEM is often expected to deliver the greatest incremental value in dense breasts, lesion stratification, and MRI-limited populations, with gradual expansion into higher-frequency follow-up and recurrence surveillance scenarios. Meanwhile, radiology leaders increasingly prioritize structured reporting, AI assistance, and cross-site consistency to operationalize quality at scale. The upstream value chain is anchored by “contrast agent & injection systems + dual-energy mammography platform + software/QA components.” Iodinated contrast media and injectors/consumables define administration stability and safety boundaries; dual-energy detectors, x-ray tubes, generators, and compression mechanics drive image consistency and reproducibility; and reconstruction/post-processing software (low-energy images, iodine/enhancement images, artifact suppression, dose management) determines readability and workflow efficiency. Competitive differentiation concentrates on balancing low dose with high contrast, user-friendly reconstruction and reading software, integration with RIS/PACS and structured reporting, and lifecycle QA and service delivery capabilities.
LP Information, Inc. (LPI) ' newest research report, the “Contrast-Enhanced Mammography Industry Forecast” looks at past sales and reviews total world Contrast-Enhanced Mammography sales in 2025, providing a comprehensive analysis by region and market sector of projected Contrast-Enhanced Mammography sales for 2026 through 2032. With Contrast-Enhanced Mammography sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contrast-Enhanced Mammography industry.
This Insight Report provides a comprehensive analysis of the global Contrast-Enhanced Mammography landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contrast-Enhanced Mammography portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contrast-Enhanced Mammography market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contrast-Enhanced Mammography and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contrast-Enhanced Mammography.
This report presents a comprehensive overview, market shares, and growth opportunities of Contrast-Enhanced Mammography market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Dual-energy CEM
- Single-energy Enhanced
- Screening
- Diagnostic Workup
- Pre-op Staging
- Other
- Dedicated CEM Mammography
- Upgrade from Standard System
- Other
- Hospital
- Physical Examination Center
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hologic
- GE Healthcare
- Siemens
- FUJIFILM
- Philips Healthcare
- Canon Medical
- IMS Giotto
- Planmed
- Carestream Health
- Metaltronica
- MEDI-FUTURE
- Wandong Medical
- ANKE
- Sino MDT
- Angell
- United Imaging Healthcare
- Alltech Healthcare
- Neusoft Healthcare
- SevenHealth
What is the 10-year outlook for the global Contrast-Enhanced Mammography market?
What factors are driving Contrast-Enhanced Mammography market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contrast-Enhanced Mammography market opportunities vary by end market size?
How does Contrast-Enhanced Mammography break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contrast-Enhanced Mammography Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Contrast-Enhanced Mammography by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Contrast-Enhanced Mammography by Country/Region, 2021, 2025 & 2032
2.2 Contrast-Enhanced Mammography Segment by Type
2.2.1 Dual-energy CEM
2.2.2 Single-energy Enhanced
2.2.3 Contrast-Enhanced Mammography Sales by Type
2.2.3.1 Global Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
2.2.3.2 Global Contrast-Enhanced Mammography Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Contrast-Enhanced Mammography Sale Price by Type (2021-2026)
2.3 Contrast-Enhanced Mammography Segment by Clinical Purpose
2.3.1 Screening
2.3.2 Diagnostic Workup
2.3.3 Pre-op Staging
2.3.4 Other
2.3.5 Contrast-Enhanced Mammography Sales by Clinical Purpose
2.3.5.1 Global Contrast-Enhanced Mammography Sales Market Share by Clinical Purpose (2021-2026)
2.3.5.2 Global Contrast-Enhanced Mammography Revenue and Market Share by Clinical Purpose (2021-2026)
2.3.5.3 Global Contrast-Enhanced Mammography Sale Price by Clinical Purpose (2021-2026)
2.4 Contrast-Enhanced Mammography Segment by Equipment Type
2.4.1 Dedicated CEM Mammography
2.4.2 Upgrade from Standard System
2.4.3 Other
2.4.4 Contrast-Enhanced Mammography Sales by Equipment Type
2.4.4.1 Global Contrast-Enhanced Mammography Sales Market Share by Equipment Type (2021-2026)
2.4.4.2 Global Contrast-Enhanced Mammography Revenue and Market Share by Equipment Type (2021-2026)
2.4.4.3 Global Contrast-Enhanced Mammography Sale Price by Equipment Type (2021-2026)
2.5 Contrast-Enhanced Mammography Segment by Application
2.5.1 Hospital
2.5.2 Physical Examination Center
2.5.3 Other
2.5.4 Contrast-Enhanced Mammography Sales by Application
2.5.4.1 Global Contrast-Enhanced Mammography Sale Market Share by Application (2021-2026)
2.5.4.2 Global Contrast-Enhanced Mammography Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Contrast-Enhanced Mammography Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Contrast-Enhanced Mammography Breakdown Data by Company
3.1.1 Global Contrast-Enhanced Mammography Annual Sales by Company (2021-2026)
3.1.2 Global Contrast-Enhanced Mammography Sales Market Share by Company (2021-2026)
3.2 Global Contrast-Enhanced Mammography Annual Revenue by Company (2021-2026)
3.2.1 Global Contrast-Enhanced Mammography Revenue by Company (2021-2026)
3.2.2 Global Contrast-Enhanced Mammography Revenue Market Share by Company (2021-2026)
3.3 Global Contrast-Enhanced Mammography Sale Price by Company
3.4 Key Manufacturers Contrast-Enhanced Mammography Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contrast-Enhanced Mammography Product Location Distribution
3.4.2 Players Contrast-Enhanced Mammography Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTRAST-ENHANCED MAMMOGRAPHY BY GEOGRAPHIC REGION
4.1 World Historic Contrast-Enhanced Mammography Market Size by Geographic Region (2021-2026)
4.1.1 Global Contrast-Enhanced Mammography Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Contrast-Enhanced Mammography Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Contrast-Enhanced Mammography Market Size by Country/Region (2021-2026)
4.2.1 Global Contrast-Enhanced Mammography Annual Sales by Country/Region (2021-2026)
4.2.2 Global Contrast-Enhanced Mammography Annual Revenue by Country/Region (2021-2026)
4.3 Americas Contrast-Enhanced Mammography Sales Growth
4.4 APAC Contrast-Enhanced Mammography Sales Growth
4.5 Europe Contrast-Enhanced Mammography Sales Growth
4.6 Middle East & Africa Contrast-Enhanced Mammography Sales Growth
5 AMERICAS
5.1 Americas Contrast-Enhanced Mammography Sales by Country
5.1.1 Americas Contrast-Enhanced Mammography Sales by Country (2021-2026)
5.1.2 Americas Contrast-Enhanced Mammography Revenue by Country (2021-2026)
5.2 Americas Contrast-Enhanced Mammography Sales by Type (2021-2026)
5.3 Americas Contrast-Enhanced Mammography Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contrast-Enhanced Mammography Sales by Region
6.1.1 APAC Contrast-Enhanced Mammography Sales by Region (2021-2026)
6.1.2 APAC Contrast-Enhanced Mammography Revenue by Region (2021-2026)
6.2 APAC Contrast-Enhanced Mammography Sales by Type (2021-2026)
6.3 APAC Contrast-Enhanced Mammography Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Contrast-Enhanced Mammography by Country
7.1.1 Europe Contrast-Enhanced Mammography Sales by Country (2021-2026)
7.1.2 Europe Contrast-Enhanced Mammography Revenue by Country (2021-2026)
7.2 Europe Contrast-Enhanced Mammography Sales by Type (2021-2026)
7.3 Europe Contrast-Enhanced Mammography Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contrast-Enhanced Mammography by Country
8.1.1 Middle East & Africa Contrast-Enhanced Mammography Sales by Country (2021-2026)
8.1.2 Middle East & Africa Contrast-Enhanced Mammography Revenue by Country (2021-2026)
8.2 Middle East & Africa Contrast-Enhanced Mammography Sales by Type (2021-2026)
8.3 Middle East & Africa Contrast-Enhanced Mammography Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contrast-Enhanced Mammography
10.3 Manufacturing Process Analysis of Contrast-Enhanced Mammography
10.4 Industry Chain Structure of Contrast-Enhanced Mammography
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contrast-Enhanced Mammography Distributors
11.3 Contrast-Enhanced Mammography Customer
12 WORLD FORECAST REVIEW FOR CONTRAST-ENHANCED MAMMOGRAPHY BY GEOGRAPHIC REGION
12.1 Global Contrast-Enhanced Mammography Market Size Forecast by Region
12.1.1 Global Contrast-Enhanced Mammography Forecast by Region (2027-2032)
12.1.2 Global Contrast-Enhanced Mammography Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Contrast-Enhanced Mammography Forecast by Type (2027-2032)
12.7 Global Contrast-Enhanced Mammography Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hologic
13.1.1 Hologic Company Information
13.1.2 Hologic Contrast-Enhanced Mammography Product Portfolios and Specifications
13.1.3 Hologic Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hologic Main Business Overview
13.1.5 Hologic Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
13.2.3 GE Healthcare Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Siemens
13.3.1 Siemens Company Information
13.3.2 Siemens Contrast-Enhanced Mammography Product Portfolios and Specifications
13.3.3 Siemens Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Siemens Main Business Overview
13.3.5 Siemens Latest Developments
13.4 FUJIFILM
13.4.1 FUJIFILM Company Information
13.4.2 FUJIFILM Contrast-Enhanced Mammography Product Portfolios and Specifications
13.4.3 FUJIFILM Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 FUJIFILM Main Business Overview
13.4.5 FUJIFILM Latest Developments
13.5 Philips Healthcare
13.5.1 Philips Healthcare Company Information
13.5.2 Philips Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
13.5.3 Philips Healthcare Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Philips Healthcare Main Business Overview
13.5.5 Philips Healthcare Latest Developments
13.6 Canon Medical
13.6.1 Canon Medical Company Information
13.6.2 Canon Medical Contrast-Enhanced Mammography Product Portfolios and Specifications
13.6.3 Canon Medical Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Canon Medical Main Business Overview
13.6.5 Canon Medical Latest Developments
13.7 IMS Giotto
13.7.1 IMS Giotto Company Information
13.7.2 IMS Giotto Contrast-Enhanced Mammography Product Portfolios and Specifications
13.7.3 IMS Giotto Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 IMS Giotto Main Business Overview
13.7.5 IMS Giotto Latest Developments
13.8 Planmed
13.8.1 Planmed Company Information
13.8.2 Planmed Contrast-Enhanced Mammography Product Portfolios and Specifications
13.8.3 Planmed Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Planmed Main Business Overview
13.8.5 Planmed Latest Developments
13.9 Carestream Health
13.9.1 Carestream Health Company Information
13.9.2 Carestream Health Contrast-Enhanced Mammography Product Portfolios and Specifications
13.9.3 Carestream Health Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Carestream Health Main Business Overview
13.9.5 Carestream Health Latest Developments
13.10 Metaltronica
13.10.1 Metaltronica Company Information
13.10.2 Metaltronica Contrast-Enhanced Mammography Product Portfolios and Specifications
13.10.3 Metaltronica Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Metaltronica Main Business Overview
13.10.5 Metaltronica Latest Developments
13.11 MEDI-FUTURE
13.11.1 MEDI-FUTURE Company Information
13.11.2 MEDI-FUTURE Contrast-Enhanced Mammography Product Portfolios and Specifications
13.11.3 MEDI-FUTURE Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MEDI-FUTURE Main Business Overview
13.11.5 MEDI-FUTURE Latest Developments
13.12 Wandong Medical
13.12.1 Wandong Medical Company Information
13.12.2 Wandong Medical Contrast-Enhanced Mammography Product Portfolios and Specifications
13.12.3 Wandong Medical Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Wandong Medical Main Business Overview
13.12.5 Wandong Medical Latest Developments
13.13 ANKE
13.13.1 ANKE Company Information
13.13.2 ANKE Contrast-Enhanced Mammography Product Portfolios and Specifications
13.13.3 ANKE Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 ANKE Main Business Overview
13.13.5 ANKE Latest Developments
13.14 Sino MDT
13.14.1 Sino MDT Company Information
13.14.2 Sino MDT Contrast-Enhanced Mammography Product Portfolios and Specifications
13.14.3 Sino MDT Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sino MDT Main Business Overview
13.14.5 Sino MDT Latest Developments
13.15 Angell
13.15.1 Angell Company Information
13.15.2 Angell Contrast-Enhanced Mammography Product Portfolios and Specifications
13.15.3 Angell Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Angell Main Business Overview
13.15.5 Angell Latest Developments
13.16 United Imaging Healthcare
13.16.1 United Imaging Healthcare Company Information
13.16.2 United Imaging Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
13.16.3 United Imaging Healthcare Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 United Imaging Healthcare Main Business Overview
13.16.5 United Imaging Healthcare Latest Developments
13.17 Alltech Healthcare
13.17.1 Alltech Healthcare Company Information
13.17.2 Alltech Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
13.17.3 Alltech Healthcare Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Alltech Healthcare Main Business Overview
13.17.5 Alltech Healthcare Latest Developments
13.18 Neusoft Healthcare
13.18.1 Neusoft Healthcare Company Information
13.18.2 Neusoft Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
13.18.3 Neusoft Healthcare Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Neusoft Healthcare Main Business Overview
13.18.5 Neusoft Healthcare Latest Developments
13.19 SevenHealth
13.19.1 SevenHealth Company Information
13.19.2 SevenHealth Contrast-Enhanced Mammography Product Portfolios and Specifications
13.19.3 SevenHealth Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 SevenHealth Main Business Overview
13.19.5 SevenHealth Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contrast-Enhanced Mammography Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Contrast-Enhanced Mammography by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Contrast-Enhanced Mammography by Country/Region, 2021, 2025 & 2032
2.2 Contrast-Enhanced Mammography Segment by Type
2.2.1 Dual-energy CEM
2.2.2 Single-energy Enhanced
2.2.3 Contrast-Enhanced Mammography Sales by Type
2.2.3.1 Global Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
2.2.3.2 Global Contrast-Enhanced Mammography Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Contrast-Enhanced Mammography Sale Price by Type (2021-2026)
2.3 Contrast-Enhanced Mammography Segment by Clinical Purpose
2.3.1 Screening
2.3.2 Diagnostic Workup
2.3.3 Pre-op Staging
2.3.4 Other
2.3.5 Contrast-Enhanced Mammography Sales by Clinical Purpose
2.3.5.1 Global Contrast-Enhanced Mammography Sales Market Share by Clinical Purpose (2021-2026)
2.3.5.2 Global Contrast-Enhanced Mammography Revenue and Market Share by Clinical Purpose (2021-2026)
2.3.5.3 Global Contrast-Enhanced Mammography Sale Price by Clinical Purpose (2021-2026)
2.4 Contrast-Enhanced Mammography Segment by Equipment Type
2.4.1 Dedicated CEM Mammography
2.4.2 Upgrade from Standard System
2.4.3 Other
2.4.4 Contrast-Enhanced Mammography Sales by Equipment Type
2.4.4.1 Global Contrast-Enhanced Mammography Sales Market Share by Equipment Type (2021-2026)
2.4.4.2 Global Contrast-Enhanced Mammography Revenue and Market Share by Equipment Type (2021-2026)
2.4.4.3 Global Contrast-Enhanced Mammography Sale Price by Equipment Type (2021-2026)
2.5 Contrast-Enhanced Mammography Segment by Application
2.5.1 Hospital
2.5.2 Physical Examination Center
2.5.3 Other
2.5.4 Contrast-Enhanced Mammography Sales by Application
2.5.4.1 Global Contrast-Enhanced Mammography Sale Market Share by Application (2021-2026)
2.5.4.2 Global Contrast-Enhanced Mammography Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Contrast-Enhanced Mammography Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Contrast-Enhanced Mammography Breakdown Data by Company
3.1.1 Global Contrast-Enhanced Mammography Annual Sales by Company (2021-2026)
3.1.2 Global Contrast-Enhanced Mammography Sales Market Share by Company (2021-2026)
3.2 Global Contrast-Enhanced Mammography Annual Revenue by Company (2021-2026)
3.2.1 Global Contrast-Enhanced Mammography Revenue by Company (2021-2026)
3.2.2 Global Contrast-Enhanced Mammography Revenue Market Share by Company (2021-2026)
3.3 Global Contrast-Enhanced Mammography Sale Price by Company
3.4 Key Manufacturers Contrast-Enhanced Mammography Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contrast-Enhanced Mammography Product Location Distribution
3.4.2 Players Contrast-Enhanced Mammography Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTRAST-ENHANCED MAMMOGRAPHY BY GEOGRAPHIC REGION
4.1 World Historic Contrast-Enhanced Mammography Market Size by Geographic Region (2021-2026)
4.1.1 Global Contrast-Enhanced Mammography Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Contrast-Enhanced Mammography Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Contrast-Enhanced Mammography Market Size by Country/Region (2021-2026)
4.2.1 Global Contrast-Enhanced Mammography Annual Sales by Country/Region (2021-2026)
4.2.2 Global Contrast-Enhanced Mammography Annual Revenue by Country/Region (2021-2026)
4.3 Americas Contrast-Enhanced Mammography Sales Growth
4.4 APAC Contrast-Enhanced Mammography Sales Growth
4.5 Europe Contrast-Enhanced Mammography Sales Growth
4.6 Middle East & Africa Contrast-Enhanced Mammography Sales Growth
5 AMERICAS
5.1 Americas Contrast-Enhanced Mammography Sales by Country
5.1.1 Americas Contrast-Enhanced Mammography Sales by Country (2021-2026)
5.1.2 Americas Contrast-Enhanced Mammography Revenue by Country (2021-2026)
5.2 Americas Contrast-Enhanced Mammography Sales by Type (2021-2026)
5.3 Americas Contrast-Enhanced Mammography Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contrast-Enhanced Mammography Sales by Region
6.1.1 APAC Contrast-Enhanced Mammography Sales by Region (2021-2026)
6.1.2 APAC Contrast-Enhanced Mammography Revenue by Region (2021-2026)
6.2 APAC Contrast-Enhanced Mammography Sales by Type (2021-2026)
6.3 APAC Contrast-Enhanced Mammography Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Contrast-Enhanced Mammography by Country
7.1.1 Europe Contrast-Enhanced Mammography Sales by Country (2021-2026)
7.1.2 Europe Contrast-Enhanced Mammography Revenue by Country (2021-2026)
7.2 Europe Contrast-Enhanced Mammography Sales by Type (2021-2026)
7.3 Europe Contrast-Enhanced Mammography Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contrast-Enhanced Mammography by Country
8.1.1 Middle East & Africa Contrast-Enhanced Mammography Sales by Country (2021-2026)
8.1.2 Middle East & Africa Contrast-Enhanced Mammography Revenue by Country (2021-2026)
8.2 Middle East & Africa Contrast-Enhanced Mammography Sales by Type (2021-2026)
8.3 Middle East & Africa Contrast-Enhanced Mammography Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contrast-Enhanced Mammography
10.3 Manufacturing Process Analysis of Contrast-Enhanced Mammography
10.4 Industry Chain Structure of Contrast-Enhanced Mammography
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contrast-Enhanced Mammography Distributors
11.3 Contrast-Enhanced Mammography Customer
12 WORLD FORECAST REVIEW FOR CONTRAST-ENHANCED MAMMOGRAPHY BY GEOGRAPHIC REGION
12.1 Global Contrast-Enhanced Mammography Market Size Forecast by Region
12.1.1 Global Contrast-Enhanced Mammography Forecast by Region (2027-2032)
12.1.2 Global Contrast-Enhanced Mammography Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Contrast-Enhanced Mammography Forecast by Type (2027-2032)
12.7 Global Contrast-Enhanced Mammography Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hologic
13.1.1 Hologic Company Information
13.1.2 Hologic Contrast-Enhanced Mammography Product Portfolios and Specifications
13.1.3 Hologic Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hologic Main Business Overview
13.1.5 Hologic Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
13.2.3 GE Healthcare Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Siemens
13.3.1 Siemens Company Information
13.3.2 Siemens Contrast-Enhanced Mammography Product Portfolios and Specifications
13.3.3 Siemens Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Siemens Main Business Overview
13.3.5 Siemens Latest Developments
13.4 FUJIFILM
13.4.1 FUJIFILM Company Information
13.4.2 FUJIFILM Contrast-Enhanced Mammography Product Portfolios and Specifications
13.4.3 FUJIFILM Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 FUJIFILM Main Business Overview
13.4.5 FUJIFILM Latest Developments
13.5 Philips Healthcare
13.5.1 Philips Healthcare Company Information
13.5.2 Philips Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
13.5.3 Philips Healthcare Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Philips Healthcare Main Business Overview
13.5.5 Philips Healthcare Latest Developments
13.6 Canon Medical
13.6.1 Canon Medical Company Information
13.6.2 Canon Medical Contrast-Enhanced Mammography Product Portfolios and Specifications
13.6.3 Canon Medical Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Canon Medical Main Business Overview
13.6.5 Canon Medical Latest Developments
13.7 IMS Giotto
13.7.1 IMS Giotto Company Information
13.7.2 IMS Giotto Contrast-Enhanced Mammography Product Portfolios and Specifications
13.7.3 IMS Giotto Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 IMS Giotto Main Business Overview
13.7.5 IMS Giotto Latest Developments
13.8 Planmed
13.8.1 Planmed Company Information
13.8.2 Planmed Contrast-Enhanced Mammography Product Portfolios and Specifications
13.8.3 Planmed Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Planmed Main Business Overview
13.8.5 Planmed Latest Developments
13.9 Carestream Health
13.9.1 Carestream Health Company Information
13.9.2 Carestream Health Contrast-Enhanced Mammography Product Portfolios and Specifications
13.9.3 Carestream Health Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Carestream Health Main Business Overview
13.9.5 Carestream Health Latest Developments
13.10 Metaltronica
13.10.1 Metaltronica Company Information
13.10.2 Metaltronica Contrast-Enhanced Mammography Product Portfolios and Specifications
13.10.3 Metaltronica Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Metaltronica Main Business Overview
13.10.5 Metaltronica Latest Developments
13.11 MEDI-FUTURE
13.11.1 MEDI-FUTURE Company Information
13.11.2 MEDI-FUTURE Contrast-Enhanced Mammography Product Portfolios and Specifications
13.11.3 MEDI-FUTURE Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MEDI-FUTURE Main Business Overview
13.11.5 MEDI-FUTURE Latest Developments
13.12 Wandong Medical
13.12.1 Wandong Medical Company Information
13.12.2 Wandong Medical Contrast-Enhanced Mammography Product Portfolios and Specifications
13.12.3 Wandong Medical Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Wandong Medical Main Business Overview
13.12.5 Wandong Medical Latest Developments
13.13 ANKE
13.13.1 ANKE Company Information
13.13.2 ANKE Contrast-Enhanced Mammography Product Portfolios and Specifications
13.13.3 ANKE Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 ANKE Main Business Overview
13.13.5 ANKE Latest Developments
13.14 Sino MDT
13.14.1 Sino MDT Company Information
13.14.2 Sino MDT Contrast-Enhanced Mammography Product Portfolios and Specifications
13.14.3 Sino MDT Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sino MDT Main Business Overview
13.14.5 Sino MDT Latest Developments
13.15 Angell
13.15.1 Angell Company Information
13.15.2 Angell Contrast-Enhanced Mammography Product Portfolios and Specifications
13.15.3 Angell Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Angell Main Business Overview
13.15.5 Angell Latest Developments
13.16 United Imaging Healthcare
13.16.1 United Imaging Healthcare Company Information
13.16.2 United Imaging Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
13.16.3 United Imaging Healthcare Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 United Imaging Healthcare Main Business Overview
13.16.5 United Imaging Healthcare Latest Developments
13.17 Alltech Healthcare
13.17.1 Alltech Healthcare Company Information
13.17.2 Alltech Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
13.17.3 Alltech Healthcare Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Alltech Healthcare Main Business Overview
13.17.5 Alltech Healthcare Latest Developments
13.18 Neusoft Healthcare
13.18.1 Neusoft Healthcare Company Information
13.18.2 Neusoft Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
13.18.3 Neusoft Healthcare Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Neusoft Healthcare Main Business Overview
13.18.5 Neusoft Healthcare Latest Developments
13.19 SevenHealth
13.19.1 SevenHealth Company Information
13.19.2 SevenHealth Contrast-Enhanced Mammography Product Portfolios and Specifications
13.19.3 SevenHealth Contrast-Enhanced Mammography Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 SevenHealth Main Business Overview
13.19.5 SevenHealth Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Contrast-Enhanced Mammography Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Contrast-Enhanced Mammography Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Dual-energy CEM
Table 4. Major Players of Single-energy Enhanced
Table 5. Global Contrast-Enhanced Mammography Sales by Type (2021-2026) & (Units)
Table 6. Global Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
Table 7. Global Contrast-Enhanced Mammography Revenue by Type (2021-2026) & ($ million)
Table 8. Global Contrast-Enhanced Mammography Revenue Market Share by Type (2021-2026)
Table 9. Global Contrast-Enhanced Mammography Sale Price by Type (2021-2026) & (K USD/Unit)
Table 10. Major Players of Screening
Table 11. Major Players of Diagnostic Workup
Table 12. Major Players of Pre-op Staging
Table 13. Major Players of Other
Table 14. Global Contrast-Enhanced Mammography Sales by Clinical Purpose (2021-2026) & (Units)
Table 15. Global Contrast-Enhanced Mammography Sales Market Share by Clinical Purpose (2021-2026)
Table 16. Global Contrast-Enhanced Mammography Revenue by Clinical Purpose (2021-2026) & ($ million)
Table 17. Global Contrast-Enhanced Mammography Revenue Market Share by Clinical Purpose (2021-2026)
Table 18. Global Contrast-Enhanced Mammography Sale Price by Clinical Purpose (2021-2026) & (K USD/Unit)
Table 19. Major Players of Dedicated CEM Mammography
Table 20. Major Players of Upgrade from Standard System
Table 21. Major Players of Other
Table 22. Global Contrast-Enhanced Mammography Sales by Equipment Type (2021-2026) & (Units)
Table 23. Global Contrast-Enhanced Mammography Sales Market Share by Equipment Type (2021-2026)
Table 24. Global Contrast-Enhanced Mammography Revenue by Equipment Type (2021-2026) & ($ million)
Table 25. Global Contrast-Enhanced Mammography Revenue Market Share by Equipment Type (2021-2026)
Table 26. Global Contrast-Enhanced Mammography Sale Price by Equipment Type (2021-2026) & (K USD/Unit)
Table 27. Global Contrast-Enhanced Mammography Sale by Application (2021-2026) & (Units)
Table 28. Global Contrast-Enhanced Mammography Sale Market Share by Application (2021-2026)
Table 29. Global Contrast-Enhanced Mammography Revenue by Application (2021-2026) & ($ million)
Table 30. Global Contrast-Enhanced Mammography Revenue Market Share by Application (2021-2026)
Table 31. Global Contrast-Enhanced Mammography Sale Price by Application (2021-2026) & (K USD/Unit)
Table 32. Global Contrast-Enhanced Mammography Sales by Company (2021-2026) & (Units)
Table 33. Global Contrast-Enhanced Mammography Sales Market Share by Company (2021-2026)
Table 34. Global Contrast-Enhanced Mammography Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Contrast-Enhanced Mammography Revenue Market Share by Company (2021-2026)
Table 36. Global Contrast-Enhanced Mammography Sale Price by Company (2021-2026) & (K USD/Unit)
Table 37. Key Manufacturers Contrast-Enhanced Mammography Producing Area Distribution and Sales Area
Table 38. Players Contrast-Enhanced Mammography Products Offered
Table 39. Contrast-Enhanced Mammography Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Contrast-Enhanced Mammography Sales by Geographic Region (2021-2026) & (Units)
Table 43. Global Contrast-Enhanced Mammography Sales Market Share Geographic Region (2021-2026)
Table 44. Global Contrast-Enhanced Mammography Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Contrast-Enhanced Mammography Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Contrast-Enhanced Mammography Sales by Country/Region (2021-2026) & (Units)
Table 47. Global Contrast-Enhanced Mammography Sales Market Share by Country/Region (2021-2026)
Table 48. Global Contrast-Enhanced Mammography Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Contrast-Enhanced Mammography Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Contrast-Enhanced Mammography Sales by Country (2021-2026) & (Units)
Table 51. Americas Contrast-Enhanced Mammography Sales Market Share by Country (2021-2026)
Table 52. Americas Contrast-Enhanced Mammography Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Contrast-Enhanced Mammography Sales by Type (2021-2026) & (Units)
Table 54. Americas Contrast-Enhanced Mammography Sales by Application (2021-2026) & (Units)
Table 55. APAC Contrast-Enhanced Mammography Sales by Region (2021-2026) & (Units)
Table 56. APAC Contrast-Enhanced Mammography Sales Market Share by Region (2021-2026)
Table 57. APAC Contrast-Enhanced Mammography Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Contrast-Enhanced Mammography Sales by Type (2021-2026) & (Units)
Table 59. APAC Contrast-Enhanced Mammography Sales by Application (2021-2026) & (Units)
Table 60. Europe Contrast-Enhanced Mammography Sales by Country (2021-2026) & (Units)
Table 61. Europe Contrast-Enhanced Mammography Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Contrast-Enhanced Mammography Sales by Type (2021-2026) & (Units)
Table 63. Europe Contrast-Enhanced Mammography Sales by Application (2021-2026) & (Units)
Table 64. Middle East & Africa Contrast-Enhanced Mammography Sales by Country (2021-2026) & (Units)
Table 65. Middle East & Africa Contrast-Enhanced Mammography Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Contrast-Enhanced Mammography Sales by Type (2021-2026) & (Units)
Table 67. Middle East & Africa Contrast-Enhanced Mammography Sales by Application (2021-2026) & (Units)
Table 68. Key Market Drivers & Growth Opportunities of Contrast-Enhanced Mammography
Table 69. Key Market Challenges & Risks of Contrast-Enhanced Mammography
Table 70. Key Industry Trends of Contrast-Enhanced Mammography
Table 71. Contrast-Enhanced Mammography Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Contrast-Enhanced Mammography Distributors List
Table 74. Contrast-Enhanced Mammography Customer List
Table 75. Global Contrast-Enhanced Mammography Sales Forecast by Region (2027-2032) & (Units)
Table 76. Global Contrast-Enhanced Mammography Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Contrast-Enhanced Mammography Sales Forecast by Country (2027-2032) & (Units)
Table 78. Americas Contrast-Enhanced Mammography Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Contrast-Enhanced Mammography Sales Forecast by Region (2027-2032) & (Units)
Table 80. APAC Contrast-Enhanced Mammography Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Contrast-Enhanced Mammography Sales Forecast by Country (2027-2032) & (Units)
Table 82. Europe Contrast-Enhanced Mammography Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Contrast-Enhanced Mammography Sales Forecast by Country (2027-2032) & (Units)
Table 84. Middle East & Africa Contrast-Enhanced Mammography Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Contrast-Enhanced Mammography Sales Forecast by Type (2027-2032) & (Units)
Table 86. Global Contrast-Enhanced Mammography Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Contrast-Enhanced Mammography Sales Forecast by Application (2027-2032) & (Units)
Table 88. Global Contrast-Enhanced Mammography Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Hologic Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 90. Hologic Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 91. Hologic Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 92. Hologic Main Business
Table 93. Hologic Latest Developments
Table 94. GE Healthcare Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 95. GE Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 96. GE Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 97. GE Healthcare Main Business
Table 98. GE Healthcare Latest Developments
Table 99. Siemens Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 100. Siemens Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 101. Siemens Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 102. Siemens Main Business
Table 103. Siemens Latest Developments
Table 104. FUJIFILM Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 105. FUJIFILM Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 106. FUJIFILM Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 107. FUJIFILM Main Business
Table 108. FUJIFILM Latest Developments
Table 109. Philips Healthcare Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 110. Philips Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 111. Philips Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 112. Philips Healthcare Main Business
Table 113. Philips Healthcare Latest Developments
Table 114. Canon Medical Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 115. Canon Medical Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 116. Canon Medical Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 117. Canon Medical Main Business
Table 118. Canon Medical Latest Developments
Table 119. IMS Giotto Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 120. IMS Giotto Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 121. IMS Giotto Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 122. IMS Giotto Main Business
Table 123. IMS Giotto Latest Developments
Table 124. Planmed Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 125. Planmed Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 126. Planmed Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 127. Planmed Main Business
Table 128. Planmed Latest Developments
Table 129. Carestream Health Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 130. Carestream Health Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 131. Carestream Health Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 132. Carestream Health Main Business
Table 133. Carestream Health Latest Developments
Table 134. Metaltronica Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 135. Metaltronica Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 136. Metaltronica Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 137. Metaltronica Main Business
Table 138. Metaltronica Latest Developments
Table 139. MEDI-FUTURE Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 140. MEDI-FUTURE Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 141. MEDI-FUTURE Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 142. MEDI-FUTURE Main Business
Table 143. MEDI-FUTURE Latest Developments
Table 144. Wandong Medical Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 145. Wandong Medical Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 146. Wandong Medical Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 147. Wandong Medical Main Business
Table 148. Wandong Medical Latest Developments
Table 149. ANKE Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 150. ANKE Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 151. ANKE Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 152. ANKE Main Business
Table 153. ANKE Latest Developments
Table 154. Sino MDT Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 155. Sino MDT Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 156. Sino MDT Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 157. Sino MDT Main Business
Table 158. Sino MDT Latest Developments
Table 159. Angell Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 160. Angell Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 161. Angell Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 162. Angell Main Business
Table 163. Angell Latest Developments
Table 164. United Imaging Healthcare Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 165. United Imaging Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 166. United Imaging Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 167. United Imaging Healthcare Main Business
Table 168. United Imaging Healthcare Latest Developments
Table 169. Alltech Healthcare Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 170. Alltech Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 171. Alltech Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 172. Alltech Healthcare Main Business
Table 173. Alltech Healthcare Latest Developments
Table 174. Neusoft Healthcare Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 175. Neusoft Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 176. Neusoft Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 177. Neusoft Healthcare Main Business
Table 178. Neusoft Healthcare Latest Developments
Table 179. SevenHealth Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 180. SevenHealth Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 181. SevenHealth Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 182. SevenHealth Main Business
Table 183. SevenHealth Latest Developments
Table 1. Contrast-Enhanced Mammography Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Contrast-Enhanced Mammography Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Dual-energy CEM
Table 4. Major Players of Single-energy Enhanced
Table 5. Global Contrast-Enhanced Mammography Sales by Type (2021-2026) & (Units)
Table 6. Global Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
Table 7. Global Contrast-Enhanced Mammography Revenue by Type (2021-2026) & ($ million)
Table 8. Global Contrast-Enhanced Mammography Revenue Market Share by Type (2021-2026)
Table 9. Global Contrast-Enhanced Mammography Sale Price by Type (2021-2026) & (K USD/Unit)
Table 10. Major Players of Screening
Table 11. Major Players of Diagnostic Workup
Table 12. Major Players of Pre-op Staging
Table 13. Major Players of Other
Table 14. Global Contrast-Enhanced Mammography Sales by Clinical Purpose (2021-2026) & (Units)
Table 15. Global Contrast-Enhanced Mammography Sales Market Share by Clinical Purpose (2021-2026)
Table 16. Global Contrast-Enhanced Mammography Revenue by Clinical Purpose (2021-2026) & ($ million)
Table 17. Global Contrast-Enhanced Mammography Revenue Market Share by Clinical Purpose (2021-2026)
Table 18. Global Contrast-Enhanced Mammography Sale Price by Clinical Purpose (2021-2026) & (K USD/Unit)
Table 19. Major Players of Dedicated CEM Mammography
Table 20. Major Players of Upgrade from Standard System
Table 21. Major Players of Other
Table 22. Global Contrast-Enhanced Mammography Sales by Equipment Type (2021-2026) & (Units)
Table 23. Global Contrast-Enhanced Mammography Sales Market Share by Equipment Type (2021-2026)
Table 24. Global Contrast-Enhanced Mammography Revenue by Equipment Type (2021-2026) & ($ million)
Table 25. Global Contrast-Enhanced Mammography Revenue Market Share by Equipment Type (2021-2026)
Table 26. Global Contrast-Enhanced Mammography Sale Price by Equipment Type (2021-2026) & (K USD/Unit)
Table 27. Global Contrast-Enhanced Mammography Sale by Application (2021-2026) & (Units)
Table 28. Global Contrast-Enhanced Mammography Sale Market Share by Application (2021-2026)
Table 29. Global Contrast-Enhanced Mammography Revenue by Application (2021-2026) & ($ million)
Table 30. Global Contrast-Enhanced Mammography Revenue Market Share by Application (2021-2026)
Table 31. Global Contrast-Enhanced Mammography Sale Price by Application (2021-2026) & (K USD/Unit)
Table 32. Global Contrast-Enhanced Mammography Sales by Company (2021-2026) & (Units)
Table 33. Global Contrast-Enhanced Mammography Sales Market Share by Company (2021-2026)
Table 34. Global Contrast-Enhanced Mammography Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Contrast-Enhanced Mammography Revenue Market Share by Company (2021-2026)
Table 36. Global Contrast-Enhanced Mammography Sale Price by Company (2021-2026) & (K USD/Unit)
Table 37. Key Manufacturers Contrast-Enhanced Mammography Producing Area Distribution and Sales Area
Table 38. Players Contrast-Enhanced Mammography Products Offered
Table 39. Contrast-Enhanced Mammography Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Contrast-Enhanced Mammography Sales by Geographic Region (2021-2026) & (Units)
Table 43. Global Contrast-Enhanced Mammography Sales Market Share Geographic Region (2021-2026)
Table 44. Global Contrast-Enhanced Mammography Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Contrast-Enhanced Mammography Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Contrast-Enhanced Mammography Sales by Country/Region (2021-2026) & (Units)
Table 47. Global Contrast-Enhanced Mammography Sales Market Share by Country/Region (2021-2026)
Table 48. Global Contrast-Enhanced Mammography Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Contrast-Enhanced Mammography Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Contrast-Enhanced Mammography Sales by Country (2021-2026) & (Units)
Table 51. Americas Contrast-Enhanced Mammography Sales Market Share by Country (2021-2026)
Table 52. Americas Contrast-Enhanced Mammography Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Contrast-Enhanced Mammography Sales by Type (2021-2026) & (Units)
Table 54. Americas Contrast-Enhanced Mammography Sales by Application (2021-2026) & (Units)
Table 55. APAC Contrast-Enhanced Mammography Sales by Region (2021-2026) & (Units)
Table 56. APAC Contrast-Enhanced Mammography Sales Market Share by Region (2021-2026)
Table 57. APAC Contrast-Enhanced Mammography Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Contrast-Enhanced Mammography Sales by Type (2021-2026) & (Units)
Table 59. APAC Contrast-Enhanced Mammography Sales by Application (2021-2026) & (Units)
Table 60. Europe Contrast-Enhanced Mammography Sales by Country (2021-2026) & (Units)
Table 61. Europe Contrast-Enhanced Mammography Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Contrast-Enhanced Mammography Sales by Type (2021-2026) & (Units)
Table 63. Europe Contrast-Enhanced Mammography Sales by Application (2021-2026) & (Units)
Table 64. Middle East & Africa Contrast-Enhanced Mammography Sales by Country (2021-2026) & (Units)
Table 65. Middle East & Africa Contrast-Enhanced Mammography Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Contrast-Enhanced Mammography Sales by Type (2021-2026) & (Units)
Table 67. Middle East & Africa Contrast-Enhanced Mammography Sales by Application (2021-2026) & (Units)
Table 68. Key Market Drivers & Growth Opportunities of Contrast-Enhanced Mammography
Table 69. Key Market Challenges & Risks of Contrast-Enhanced Mammography
Table 70. Key Industry Trends of Contrast-Enhanced Mammography
Table 71. Contrast-Enhanced Mammography Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Contrast-Enhanced Mammography Distributors List
Table 74. Contrast-Enhanced Mammography Customer List
Table 75. Global Contrast-Enhanced Mammography Sales Forecast by Region (2027-2032) & (Units)
Table 76. Global Contrast-Enhanced Mammography Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Contrast-Enhanced Mammography Sales Forecast by Country (2027-2032) & (Units)
Table 78. Americas Contrast-Enhanced Mammography Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Contrast-Enhanced Mammography Sales Forecast by Region (2027-2032) & (Units)
Table 80. APAC Contrast-Enhanced Mammography Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Contrast-Enhanced Mammography Sales Forecast by Country (2027-2032) & (Units)
Table 82. Europe Contrast-Enhanced Mammography Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Contrast-Enhanced Mammography Sales Forecast by Country (2027-2032) & (Units)
Table 84. Middle East & Africa Contrast-Enhanced Mammography Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Contrast-Enhanced Mammography Sales Forecast by Type (2027-2032) & (Units)
Table 86. Global Contrast-Enhanced Mammography Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Contrast-Enhanced Mammography Sales Forecast by Application (2027-2032) & (Units)
Table 88. Global Contrast-Enhanced Mammography Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Hologic Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 90. Hologic Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 91. Hologic Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 92. Hologic Main Business
Table 93. Hologic Latest Developments
Table 94. GE Healthcare Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 95. GE Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 96. GE Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 97. GE Healthcare Main Business
Table 98. GE Healthcare Latest Developments
Table 99. Siemens Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 100. Siemens Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 101. Siemens Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 102. Siemens Main Business
Table 103. Siemens Latest Developments
Table 104. FUJIFILM Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 105. FUJIFILM Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 106. FUJIFILM Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 107. FUJIFILM Main Business
Table 108. FUJIFILM Latest Developments
Table 109. Philips Healthcare Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 110. Philips Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 111. Philips Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 112. Philips Healthcare Main Business
Table 113. Philips Healthcare Latest Developments
Table 114. Canon Medical Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 115. Canon Medical Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 116. Canon Medical Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 117. Canon Medical Main Business
Table 118. Canon Medical Latest Developments
Table 119. IMS Giotto Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 120. IMS Giotto Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 121. IMS Giotto Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 122. IMS Giotto Main Business
Table 123. IMS Giotto Latest Developments
Table 124. Planmed Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 125. Planmed Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 126. Planmed Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 127. Planmed Main Business
Table 128. Planmed Latest Developments
Table 129. Carestream Health Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 130. Carestream Health Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 131. Carestream Health Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 132. Carestream Health Main Business
Table 133. Carestream Health Latest Developments
Table 134. Metaltronica Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 135. Metaltronica Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 136. Metaltronica Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 137. Metaltronica Main Business
Table 138. Metaltronica Latest Developments
Table 139. MEDI-FUTURE Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 140. MEDI-FUTURE Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 141. MEDI-FUTURE Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 142. MEDI-FUTURE Main Business
Table 143. MEDI-FUTURE Latest Developments
Table 144. Wandong Medical Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 145. Wandong Medical Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 146. Wandong Medical Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 147. Wandong Medical Main Business
Table 148. Wandong Medical Latest Developments
Table 149. ANKE Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 150. ANKE Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 151. ANKE Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 152. ANKE Main Business
Table 153. ANKE Latest Developments
Table 154. Sino MDT Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 155. Sino MDT Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 156. Sino MDT Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 157. Sino MDT Main Business
Table 158. Sino MDT Latest Developments
Table 159. Angell Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 160. Angell Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 161. Angell Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 162. Angell Main Business
Table 163. Angell Latest Developments
Table 164. United Imaging Healthcare Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 165. United Imaging Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 166. United Imaging Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 167. United Imaging Healthcare Main Business
Table 168. United Imaging Healthcare Latest Developments
Table 169. Alltech Healthcare Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 170. Alltech Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 171. Alltech Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 172. Alltech Healthcare Main Business
Table 173. Alltech Healthcare Latest Developments
Table 174. Neusoft Healthcare Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 175. Neusoft Healthcare Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 176. Neusoft Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 177. Neusoft Healthcare Main Business
Table 178. Neusoft Healthcare Latest Developments
Table 179. SevenHealth Basic Information, Contrast-Enhanced Mammography Manufacturing Base, Sales Area and Its Competitors
Table 180. SevenHealth Contrast-Enhanced Mammography Product Portfolios and Specifications
Table 181. SevenHealth Contrast-Enhanced Mammography Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 182. SevenHealth Main Business
Table 183. SevenHealth Latest Developments
LIST OF FIGURES
Figure 1. Picture of Contrast-Enhanced Mammography
Figure 2. Contrast-Enhanced Mammography Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contrast-Enhanced Mammography Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Contrast-Enhanced Mammography Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Contrast-Enhanced Mammography Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Contrast-Enhanced Mammography Sales Market Share by Country/Region (2025)
Figure 10. Contrast-Enhanced Mammography Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Dual-energy CEM
Figure 12. Product Picture of Single-energy Enhanced
Figure 13. Global Contrast-Enhanced Mammography Sales Market Share by Type in 2026
Figure 14. Global Contrast-Enhanced Mammography Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Screening
Figure 16. Product Picture of Diagnostic Workup
Figure 17. Product Picture of Pre-op Staging
Figure 18. Product Picture of Other
Figure 19. Global Contrast-Enhanced Mammography Sales Market Share by Clinical Purpose in 2026
Figure 20. Global Contrast-Enhanced Mammography Revenue Market Share by Clinical Purpose (2021-2026)
Figure 21. Product Picture of Dedicated CEM Mammography
Figure 22. Product Picture of Upgrade from Standard System
Figure 23. Product Picture of Other
Figure 24. Global Contrast-Enhanced Mammography Sales Market Share by Equipment Type in 2026
Figure 25. Global Contrast-Enhanced Mammography Revenue Market Share by Equipment Type (2021-2026)
Figure 26. Contrast-Enhanced Mammography Consumed in Hospital
Figure 27. Global Contrast-Enhanced Mammography Market: Hospital (2021-2026) & (Units)
Figure 28. Contrast-Enhanced Mammography Consumed in Physical Examination Center
Figure 29. Global Contrast-Enhanced Mammography Market: Physical Examination Center (2021-2026) & (Units)
Figure 30. Contrast-Enhanced Mammography Consumed in Other
Figure 31. Global Contrast-Enhanced Mammography Market: Other (2021-2026) & (Units)
Figure 32. Global Contrast-Enhanced Mammography Sale Market Share by Application (2025)
Figure 33. Global Contrast-Enhanced Mammography Revenue Market Share by Application in 2026
Figure 34. Contrast-Enhanced Mammography Sales by Company in 2026 (Units)
Figure 35. Global Contrast-Enhanced Mammography Sales Market Share by Company in 2026
Figure 36. Contrast-Enhanced Mammography Revenue by Company in 2026 ($ millions)
Figure 37. Global Contrast-Enhanced Mammography Revenue Market Share by Company in 2026
Figure 38. Global Contrast-Enhanced Mammography Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Contrast-Enhanced Mammography Revenue Market Share by Geographic Region in 2026
Figure 40. Americas Contrast-Enhanced Mammography Sales 2021-2026 (Units)
Figure 41. Americas Contrast-Enhanced Mammography Revenue 2021-2026 ($ millions)
Figure 42. APAC Contrast-Enhanced Mammography Sales 2021-2026 (Units)
Figure 43. APAC Contrast-Enhanced Mammography Revenue 2021-2026 ($ millions)
Figure 44. Europe Contrast-Enhanced Mammography Sales 2021-2026 (Units)
Figure 45. Europe Contrast-Enhanced Mammography Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Contrast-Enhanced Mammography Sales 2021-2026 (Units)
Figure 47. Middle East & Africa Contrast-Enhanced Mammography Revenue 2021-2026 ($ millions)
Figure 48. Americas Contrast-Enhanced Mammography Sales Market Share by Country in 2026
Figure 49. Americas Contrast-Enhanced Mammography Revenue Market Share by Country (2021-2026)
Figure 50. Americas Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
Figure 51. Americas Contrast-Enhanced Mammography Sales Market Share by Application (2021-2026)
Figure 52. United States Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Contrast-Enhanced Mammography Sales Market Share by Region in 2026
Figure 57. APAC Contrast-Enhanced Mammography Revenue Market Share by Region (2021-2026)
Figure 58. APAC Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
Figure 59. APAC Contrast-Enhanced Mammography Sales Market Share by Application (2021-2026)
Figure 60. China Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 64. India Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Contrast-Enhanced Mammography Sales Market Share by Country in 2026
Figure 68. Europe Contrast-Enhanced Mammography Revenue Market Share by Country (2021-2026)
Figure 69. Europe Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
Figure 70. Europe Contrast-Enhanced Mammography Sales Market Share by Application (2021-2026)
Figure 71. Germany Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 72. France Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Contrast-Enhanced Mammography Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Contrast-Enhanced Mammography Sales Market Share by Application (2021-2026)
Figure 79. Egypt Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Contrast-Enhanced Mammography in 2026
Figure 85. Manufacturing Process Analysis of Contrast-Enhanced Mammography
Figure 86. Industry Chain Structure of Contrast-Enhanced Mammography
Figure 87. Channels of Distribution
Figure 88. Global Contrast-Enhanced Mammography Sales Market Forecast by Region (2027-2032)
Figure 89. Global Contrast-Enhanced Mammography Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Contrast-Enhanced Mammography Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Contrast-Enhanced Mammography Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Contrast-Enhanced Mammography Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Contrast-Enhanced Mammography Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Contrast-Enhanced Mammography
Figure 2. Contrast-Enhanced Mammography Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contrast-Enhanced Mammography Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Contrast-Enhanced Mammography Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Contrast-Enhanced Mammography Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Contrast-Enhanced Mammography Sales Market Share by Country/Region (2025)
Figure 10. Contrast-Enhanced Mammography Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Dual-energy CEM
Figure 12. Product Picture of Single-energy Enhanced
Figure 13. Global Contrast-Enhanced Mammography Sales Market Share by Type in 2026
Figure 14. Global Contrast-Enhanced Mammography Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Screening
Figure 16. Product Picture of Diagnostic Workup
Figure 17. Product Picture of Pre-op Staging
Figure 18. Product Picture of Other
Figure 19. Global Contrast-Enhanced Mammography Sales Market Share by Clinical Purpose in 2026
Figure 20. Global Contrast-Enhanced Mammography Revenue Market Share by Clinical Purpose (2021-2026)
Figure 21. Product Picture of Dedicated CEM Mammography
Figure 22. Product Picture of Upgrade from Standard System
Figure 23. Product Picture of Other
Figure 24. Global Contrast-Enhanced Mammography Sales Market Share by Equipment Type in 2026
Figure 25. Global Contrast-Enhanced Mammography Revenue Market Share by Equipment Type (2021-2026)
Figure 26. Contrast-Enhanced Mammography Consumed in Hospital
Figure 27. Global Contrast-Enhanced Mammography Market: Hospital (2021-2026) & (Units)
Figure 28. Contrast-Enhanced Mammography Consumed in Physical Examination Center
Figure 29. Global Contrast-Enhanced Mammography Market: Physical Examination Center (2021-2026) & (Units)
Figure 30. Contrast-Enhanced Mammography Consumed in Other
Figure 31. Global Contrast-Enhanced Mammography Market: Other (2021-2026) & (Units)
Figure 32. Global Contrast-Enhanced Mammography Sale Market Share by Application (2025)
Figure 33. Global Contrast-Enhanced Mammography Revenue Market Share by Application in 2026
Figure 34. Contrast-Enhanced Mammography Sales by Company in 2026 (Units)
Figure 35. Global Contrast-Enhanced Mammography Sales Market Share by Company in 2026
Figure 36. Contrast-Enhanced Mammography Revenue by Company in 2026 ($ millions)
Figure 37. Global Contrast-Enhanced Mammography Revenue Market Share by Company in 2026
Figure 38. Global Contrast-Enhanced Mammography Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Contrast-Enhanced Mammography Revenue Market Share by Geographic Region in 2026
Figure 40. Americas Contrast-Enhanced Mammography Sales 2021-2026 (Units)
Figure 41. Americas Contrast-Enhanced Mammography Revenue 2021-2026 ($ millions)
Figure 42. APAC Contrast-Enhanced Mammography Sales 2021-2026 (Units)
Figure 43. APAC Contrast-Enhanced Mammography Revenue 2021-2026 ($ millions)
Figure 44. Europe Contrast-Enhanced Mammography Sales 2021-2026 (Units)
Figure 45. Europe Contrast-Enhanced Mammography Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Contrast-Enhanced Mammography Sales 2021-2026 (Units)
Figure 47. Middle East & Africa Contrast-Enhanced Mammography Revenue 2021-2026 ($ millions)
Figure 48. Americas Contrast-Enhanced Mammography Sales Market Share by Country in 2026
Figure 49. Americas Contrast-Enhanced Mammography Revenue Market Share by Country (2021-2026)
Figure 50. Americas Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
Figure 51. Americas Contrast-Enhanced Mammography Sales Market Share by Application (2021-2026)
Figure 52. United States Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Contrast-Enhanced Mammography Sales Market Share by Region in 2026
Figure 57. APAC Contrast-Enhanced Mammography Revenue Market Share by Region (2021-2026)
Figure 58. APAC Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
Figure 59. APAC Contrast-Enhanced Mammography Sales Market Share by Application (2021-2026)
Figure 60. China Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 64. India Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Contrast-Enhanced Mammography Sales Market Share by Country in 2026
Figure 68. Europe Contrast-Enhanced Mammography Revenue Market Share by Country (2021-2026)
Figure 69. Europe Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
Figure 70. Europe Contrast-Enhanced Mammography Sales Market Share by Application (2021-2026)
Figure 71. Germany Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 72. France Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Contrast-Enhanced Mammography Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Contrast-Enhanced Mammography Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Contrast-Enhanced Mammography Sales Market Share by Application (2021-2026)
Figure 79. Egypt Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Contrast-Enhanced Mammography Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Contrast-Enhanced Mammography in 2026
Figure 85. Manufacturing Process Analysis of Contrast-Enhanced Mammography
Figure 86. Industry Chain Structure of Contrast-Enhanced Mammography
Figure 87. Channels of Distribution
Figure 88. Global Contrast-Enhanced Mammography Sales Market Forecast by Region (2027-2032)
Figure 89. Global Contrast-Enhanced Mammography Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Contrast-Enhanced Mammography Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Contrast-Enhanced Mammography Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Contrast-Enhanced Mammography Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Contrast-Enhanced Mammography Revenue Market Share Forecast by Application (2027-2032)
